The lower secretion of IgM and IgG in patients during the study might be due to the abnormal transmission of the TLR9-STAT3 signal pathway, which weakened the immune response, slowed the secretion of antibodies, shifted the peak of antibody secretion, then led to patients' repeated Candida infection. This evidence concerns the gene STAT3 and candidiasis.